We have always known that vaccines are cost-effective. In an unpredictable world, they are also strategic. Canada is rightly investing in the capacity to build its immune arsenal. The harder question—and the more urgent one—is whether we are ready to use it.
Canada must move beyond assuming that a single-payer model alone can solve systemic gaps in access, and design a truly universal system that works alongside private plans.